Drummond Knight Asset Management Pty Ltd Buys Shares of 383,610 Corteva, Inc. $CTVA

Drummond Knight Asset Management Pty Ltd purchased a new position in Corteva, Inc. (NYSE:CTVA) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 383,610 shares of the company’s stock, valued at approximately $25,713,000. Corteva accounts for about 7.2% of Drummond Knight Asset Management Pty Ltd’s investment portfolio, making the stock its 6th biggest position. Drummond Knight Asset Management Pty Ltd owned about 0.06% of Corteva at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CTVA. Flagship Harbor Advisors LLC bought a new stake in Corteva during the fourth quarter worth about $173,000. Cidel Asset Management Inc. boosted its position in Corteva by 8.5% during the fourth quarter. Cidel Asset Management Inc. now owns 4,290 shares of the company’s stock valued at $288,000 after buying an additional 337 shares during the period. Leo Wealth LLC boosted its position in Corteva by 6.7% during the fourth quarter. Leo Wealth LLC now owns 7,568 shares of the company’s stock valued at $507,000 after buying an additional 473 shares during the period. Sowell Financial Services LLC boosted its holdings in shares of Corteva by 40.0% during the fourth quarter. Sowell Financial Services LLC now owns 5,078 shares of the company’s stock worth $340,000 after purchasing an additional 1,452 shares during the period. Finally, Meridian Investment Counsel Inc. boosted its holdings in shares of Corteva by 4.3% during the fourth quarter. Meridian Investment Counsel Inc. now owns 7,177 shares of the company’s stock worth $481,000 after purchasing an additional 299 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Down 1.4%

Shares of CTVA stock opened at $84.28 on Tuesday. The stock has a market cap of $56.58 billion, a P/E ratio of 53.34, a PEG ratio of 2.92 and a beta of 0.68. Corteva, Inc. has a 52 week low of $53.40 and a 52 week high of $85.56. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The company’s fifty day simple moving average is $77.86 and its two-hundred day simple moving average is $70.19.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business’s quarterly revenue was down 1.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, March 2nd. Corteva’s dividend payout ratio is presently 45.57%.

Insider Buying and Selling at Corteva

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on CTVA shares. Wolfe Research increased their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Oppenheimer set a $86.00 target price on shares of Corteva in a research note on Thursday, February 5th. BNP Paribas Exane raised their price target on shares of Corteva from $72.00 to $74.00 in a research report on Monday, March 9th. Wells Fargo & Company raised their price target on shares of Corteva from $77.00 to $85.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Citigroup raised their target price on shares of Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, Corteva currently has an average rating of “Moderate Buy” and a consensus target price of $83.19.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.